Molecular epidemiology of malaria in Yaounde, Cameroon V. Analysis of the omega repetitive region of the Plasmodium falciparum CG2 gene and chloroquine resistance

American Journal of Tropical Medicine and Hygiene

Volumn 61, Issue 5, 1999, Pages 807-813

  Basco, Leonardo K ^a   Ringwald, Pascal ^a  

^a Laboratoire de Recherche sur le Paludisme Yaounde   (Cameroon)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; CHLOROQUINE; DNA;

ADOLESCENT; ADULT; ARTICLE; CAMEROON; CHILD; DNA SEQUENCE; GENE MUTATION; HUMAN; MAJOR CLINICAL STUDY; MALARIA; NONHUMAN; PLASMODIUM FALCIPARUM; POINT MUTATION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

PLASMODIUM FALCIPARUM; PROTOZOA;

EID: 0032736113     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.1999.61.807     Document Type: Article

References (43)

1. World Health Organization, 1996. Management of Uncomplicated Malaria and the Use of Antimalarial Drugs for the Protection of Travelers. Geneva: World Health Organization, WHO/MAL/96.1075.
2. Yayon A, Timberg R, Friedman S, Ginsburg H, 1984. Effects of chloroquine on the feeding mechanism of the intraerythrocytic human malarial parasite Plasmodium falciparum. J Protozool 31: 367-372.
3. Yayon A, Cabantchik ZI, Ginsburg H, 1984. Identification of the acidic compartment of Plasmodium falciparum-infected human erythrocytes as the target of the antimalarial drug chloroquine. EMBO J 3: 2695-2700.
4. Foley M, Tilley L, 1998. Quinoline antimalarials: mechanisms of action and resistance and prospects for new agents. Pharmacol Ther 79: 55-87.
5. Verdier F, Le Bras J, Clavier F, Hatin I, Blayo MC, 1985. Chloroquine uptake by Plasmodium falciparum-infected human erythrocytes during in vitro culture and its relationship to chloroquine resistance. Antimicrob Agents Chemother 27: 561-564.
6. Krogstad DJ, Gluzman IY, Kyle DE, Oduola AM, Martin SK, Milhous WK, Schlesinger PH, 1987. Efflux of chloroquine from Plasmodium falciparum: mechanism of chloroquine resistance. Science 238: 1283-1285.
7. Ginsburg H, 1990. Antimalarial drugs: is the lysosomotropic hypothesis still valid? Parasitol Today 6: 334-337.
8. Sanchez CP, Wünsch S, Lanzer M, 1997. Identification of a chloroquine importer in Plasmodium falciparum. J Biol Chem 272: 2652-2658.
9. Wilson CM, Serrano AE, Wasley A, Bogenschutz MP, Shankar AH, Wirth DF, 1989. Amplification of a gene related to mammalian mdr genes in drug-resistant Plasmodium falciparum. Science 244: 1184-1186.
10. Foote SJ, Thompson JK, Cowman AF, Kemp DJ, 1989. Amplification of the multidrug resistance gene in some chloroquine-resistant isolates of P. falciparum. Cell 57: 921-930.
11. van Es HHG, Renkema H, Aerts H, Schurr E, 1994. Enhanced lysosomal acidification leads to increased chloroquine accumulation in CHO cells expressing the pfmdr 1 gene. Mol Biochem Parasitol 68: 209-219.
12. Volkman SK, Cowman AF, Wirth DF, 1995. Functional complementation of the ste 6 gene of Saccharomyces cerevisiae with the pfmdr 1 gene of Plasmodium falciparum. Proc Natl Acad Sci USA 92: 8921-8925.
13. Ruetz S, Delling U, Brault M, Schurr E, Gros P, 1996. The pfmdr 1 gene of Plasmodium falciparum confers cellular resistance to antimalarial drugs in yeast cells. Proc Natl Acad Sci USA 93: 9942-9947.
14. Su XZ, Kirkman LA, Fujioka H, Wellems TE, 1997. Complex polymorphisms in an ∼ 330 kDa protein are linked to chloroquine-resistant P. falciparum in Southeast Asia and Africa. Cell 91: 593-603.
15. + exchanger of Plasmodium falciparum? Cell 92: 601-602.
16. + exchangers. Cell 94: 285-286.
17. Basco LK, Ringwald P, 1998. Molecular epidemiology of malaria in Yaounde, Cameroon. III. Analysis of chloroquine resistance and point mutations in the multidrug resistance 1 (pfmdr 1) gene of Plasmodium falciparum. Am J Trop Med Hyg 59: 577-581.
18. Ringwald P, Bickii J, Basco L, 1996. Randomised trial of pyronaridine versus chloroquine for acute uncomplicated falciparum malaria in Africa. Lancet 347: 24-28.
19. Ringwald P, Bickii J, Basco LK, 1998. Efficacy of oral pyronaridine for the treatment of acute uncomplicated falciparum malaria in African children. Clin Infect Dis 26: 946-953.
20. Mount DL, Nahlen BL, Patchen LC, Churchill FC, 1989. Adaptations of the Saker-Solomons test: simple, reliable colorimetric field assays for chloroquine and its metabolites in urine. Bull World Health Organ 67: 295-300.
21. Warrell DA, Molyneux ME, Beales PF, 1990. Severe and complicated malaria. Trans R Soc Trop Med Hyg 84 (suppl): 1-65.
22. Trager W, Jensen JB, 1976. Human malaria parasites in continuous culture. Science 193: 673-675.
23. Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA, Struhl K, 1995. Short Protocols in Molecular Biology. Third edition. New York: John Wiley & Sons, Inc.
24. Desjardins RE, Canfield CJ, Haynes JD, Chulay JD, 1979. Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique. Antimicrob Agents Chemother 16: 710-718.
25. Ringwald P, Bickii J, Basco LK, 1996. In vitro activity of antimalarials against clinical isolates of Plasmodium falciparum in Yaounde, Cameroon. Am J Trop Med Hyg 55: 254-258.
26. Bickii J, Basco LK, Ringwald P, 1998. Assessment of three in vitro tests and an in vivo test for chloroquine resistance in Plasmodium falciparum clinical isolates. J Clin Microbiol 36: 243-247.
27. Ringwald P, Basco LK, 1999. Comparison of in vivo and in vitro tests of resistance in patients treated with chloroquine in Yaounde, Cameroon. Bull World Health Organ 77: 34-43.
28. World Health Organization, 1996. Assessment of Therapeutic Efficacy for Uncomplicated Falciparum Malaria in Areas with Intense Transmission. Geneva: World Health Organization, WHO/MAL/96.1077.
29. Louis JP, Hengy C, Louis FJ, Gazin P, Jambou R, Gardon J, Fadat G, Trebucq A, 1992. Proposals for a new therapeutic strategy for simple Plasmodium falciparum malaria attacks in Cameroon. Trop Med Parasitol 43: 118-120.
30. Basco LK, Bickii J, Ringwald P, 1998. In vitro activity of lumefantrine (benflumetol) against clinical isolates of Plasmodium falciparum in Yaounde, Cameroon. Antimicrob Agents Chemother 42: 2347-2351.
31. Ringwald P, Bickii J, Basco LK, 1999. In vitro activity of dihydroartemisinin against clinical isolates of Plasmodium falciparum in Yaounde, Cameroon. Am J Trop Med Hyg 61: 187-192.
32. World Health Organization, 1999. International Travel and Health. Vaccination Requirements and Health Advice. Geneva: World Health Organization.
33. Snewin VA, England SM, Sims PFG, Hyde JE, 1989. Characterization of the dihydrofolate reductase-thymidylate synthetase gene from human malaria parasites highly resistant to pyrimethamine. Gene 76: 41-52.
34. Foote SJ, Galatas D, Cowman AF, 1990. Amino acids in the dihydrofolate reductase-thymidylate synthase gene of Plasmodium falciparum involved in cycloguanil resistance differ from those involved in pyrimethamine resistance. Proc Natl Acad Sci USA 87: 3014-3017.
35. Peterson DS, Milhous WK, Wellems TE, 1990. Molecular basis of differential resistance to cycloguanil and pyrimethamine in Plasmodium falciparum malaria. Proc Natl Acad Sci USA 87: 3018-3022.
36. Brooks DR, Wang P, Read M, Watkins WM, Sims PFG, Hyde JE, 1994. Sequence variation of the hydroxymethyldihydropterin pyrophosphokinase-dihydropteroate synthase gene in lines of the human malaria parasite, Plasmodium falciparum, with differing resistance to sulfadoxine. Eur J Biochem 2: 397-405.
37. Triglia T, Cowman AF, 1994. Primary structure and expression of the dihydropteroate synthetase gene of Plasmodium falciparum. Proc Natl Acad Sci USA 91: 7149-7153.
38. Basco LK, Ringwald P, 1998. Molecular epidemiology of malaria in Yaounde, Cameroon. I. Analysis of point mutations in the dihydrofolate reductase-thymidylate synthase gene of Plasmodium falciparum. Am J Trop Med Hyg 58: 369-373.
39. Basco LK, Ringwald P, 1998. Molecular epidemiology of malaria in Yaounde, Cameroon. II. Baseline frequency of point mutations in the dihydropteroate synthase gene of Plasmodium falciparum. Am J Trop Med Hyg 58: 374-377.
40. Basco LK, Tahar R, Ringwald P, 1998. Molecular basis of in vivo resistance to sulfadoxine-pyrimethamine in African adult patients infected with Plasmodium falciparum malaria parasites. Antimicrob Agents Chemother 42: 1811-1814.
41. Foote SJ, Kyle DE, Martin RK, Oduola AMJ, Forsyth K, Kemp DJ, Cowman AF, 1990. Several alleles of the multidrug-resistance gene are closely linked to chloroquine resistance in Plasmodium falciparum. Nature 345: 255-258.
42. Basco LK, Le Bras J, Rhoades Z, Wilson CM, 1995. Analysis of pfmdr 1 and drug susceptibility in fresh isolates of Plasmodium falciparum from sub-Saharan Africa. Mol Biochem Parasitol 74: 157-166.
43. Basco LK, Ringwald P, 1997. pfmdr I gene mutation and clinical response to chloroquine in Yaounde, Cameroon. Trans R Soc Trop Med Hyg 91: 210-211.